ProfileGDS4095 / 201785_at
TitleTamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OrganismHomo sapiens


SRC1 knockdown control tamoxifen untreated tamoxifen untreated GSM709767 GSM709769 GSM709765 GSM709771 GSM709772 GSM709775 GSM709764 GSM709766 GSM709768 GSM709777 GSM709770 GSM709773 GSM709774 GSM709776 36% 38% 29% 30% 35% 26% 31% 34% 32% 21% 27% 30% 25% 42% sort by genotype/variation sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM709767LY2 SRC1-siRNA tamoxifen treated rep12.5707236
GSM709769LY2 SRC1-siRNA tamoxifen treated rep32.6761438
GSM709765LY2 SRC1-siRNA untreated rep32.3216429
GSM709771LY2 SRC1-siRNA untreated rep12.3482130
GSM709772LY2 SRC1-siRNA untreated rep22.5475935
GSM709775LY2 SRC1-siRNA untreated rep42.227226
GSM709764LY2 control-siRNA tamoxifen treated rep22.3906831
GSM709766LY2 control-siRNA tamoxifen treated rep32.5193934
GSM709768LY2 control-siRNA tamoxifen treated rep12.4281832
GSM709777LY2 control-siRNA tamoxifen treated rep42.0791521
GSM709770LY2 control-siRNA untreated rep32.2217527
GSM709773LY2 control-siRNA untreated rep12.3716330
GSM709774LY2 control-siRNA untreated rep22.1971825
GSM709776LY2 control-siRNA untreated rep42.8694742